stockrowAlvotech (ALVO) vs ANI Pharmaceuticals, Inc. (ANIP)
- Alvotech ALVO 4.86 +6.81%
- ANI Pharmaceuticals, Inc. ANIP 68.56 −1.52%
Alvotech and ANI Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Alvotech is the larger, with a market value of $1.8B against $1.6B — 1.1× the size. Alvotech has negative trailing earnings, so its P/E is not meaningful; ANI Pharmaceuticals, Inc. trades at 13.3×. Alvotech grew revenue faster over the last twelve months: 364.3% against 25.9%. ANI Pharmaceuticals, Inc. has the higher net margin (11.2% vs −101.1%) and the higher return on invested capital (46.4% vs 0.00%). Across the 16 metrics below, ANI Pharmaceuticals, Inc. leads on 14 and Alvotech on 2.
Valuation
Profitability
| Metric | ALVO | ANIP | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 42.71% | 61.06% | 53.51% |
| Operating margin | (42.43%) | 15.99% | 0.00% |
| Net margin | (101.05%) | 11.22% | (2.45%) |
| Free cash flow margin | 0.00% | 19.72% | 0.00% |
| Return on equity | 0.00% | 20.45% | (0.80%) |
| Return on assets | 0.00% | 7.85% | (1.67%) |
| Return on invested capital | 0.00% | 46.43% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack